Intellectual Property

Kirkland & Ellis has an outstanding practice group known for its trial capabilities. The team regularly handles patent disputes in addition to its wider expertise bringing actions to enforce trademarks and trade secret rights. The firm's clients include some of the largest blue-chip companies active in the pharmaceutical, life sciences and technology sectors. The team can boast experienced counsel for Abbreviated New Drug Application (ANDA) litigation and has increasing presence in the growing biosimilars market. It is also noted for its adept handling of USPTO post-grant review proceedings.